Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
AICISDA Cover

Continuing Education Credits for Physicians, Psychologists, and Counselors will be awarded.

The NIH/FAES is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The NIH/FAES designates this educational activity for a maximum of 12 hours in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.

NIDA is authorized by regulations under Title 10, Subtitle 36, Chapter .05B of the Maryland Board of Examiners of Psychologists to award 12 hours of Category B credit to psychologists for this activity.

As an approved provider under the National Association of Alcoholism and Drug Abuse Counselors Educational Provider Program, NIDA's Continuing Education Program has approved this educational activity for 12 hours of credit for counselors (Provider #000226).


Assessing the Impact of Childhood Interventions on Subsequent Drug Abuse

 

Little is known about the impact of mental health treatments for childhood psychopathologies on subsequent risk for drug abuse. The purpose of this meeting is to stimulate development of this important research area.


May 23


9:00 am Welcome Alan I. Leshner, Ph.D.
Director, National Institute on Drug Abuse
9:10 am Welcome Steven E. Hyman, M.D.
Director, National Institute of Mental Health
9:20 am Introductory Remarks Meyer D. Glantz, Ph.D.
Division of Epidemiology and Prevention Research, NIDA
9:30 am -12:30 pm Session I Basics
A research-based review of the epidemiology, neurobiology, and risk factors for comorbid psychiatric and substance use disorders in a developmental context.
12:30 - 2:00 pm Lunch
(provided on site)
 
2:00 - 5:00 pm Session II Ongoing Treatment Studies
Examples of treatment studies targeting various disorders, populations, and interventions with substance abuse and other outcome measures.


May 24


9 am - 12:30 pm Session III Methodological Challenges
Resources and strategies for measuring substance abuse and related risk factors and for addressing followup, design, and analysis problems.
12:30 - 2:00 pm Lunch
(provided on site)
 
2:00 - 4:00 pm Session IV Research Implementation
Realities of implementing studies on drug abuse and related behaviors, including special considerations of sample retention, ethical and legal matters, and scientific collaboration.
4:00 - 4:30 pm Wrap-up Synthesis and Future Directions


Target Audience: Those with an interest in conducting research on the treatment of childhood psychopathologies and the effect of such treatment on future substance abuse trajectories.

Disability: If you are a person with a disability and require assistance, please contact Management Assistance Corporation at least 5 business days in advance of this activity.

 



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal